SciClone Pharmaceuticals (SCLN) Announces Quarterly Earnings, Beats Estimates By $0.02 EPS
SciClone Pharmaceuticals (NASDAQ:SCLN) released its earnings data on Monday. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02, Stock Ratings News reports. The company had revenue of $26.60 million for the quarter, compared to the consensus estimate of $32.20 million.
Shares of SciClone Pharmaceuticals (NASDAQ:SCLN) opened at 4.78 on Monday. SciClone Pharmaceuticals has a 1-year low of $4.24 and a 1-year high of $6.30. The stock’s 50-day moving average is $4.58 and its 200-day moving average is $4.77. The company has a market cap of $248.4 million and a P/E ratio of 23.45.
SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) is a specialty pharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.